BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2011
View Archived Issues
QLT reports promising phase II data on L-PPDS in glaucoma
Read More
Bristol-Myers Squibb small-molecule MAP kinase p38 alpha inhibitor shows promise to treat arthritis
Read More
Pfizer describes discovery and investigation of AMPA receptor modulator now in phase I
Read More
Additional analyses of AVERROES study presented
Read More
Daewoong Pharmaceutical discloses new antifungal agents
Read More
Novel plant extracts prepared by German researchers
Read More
Hanmi Holdings presents new epidermal growth factor receptor inhibitors
Read More
Nanoemulsion-based RSV vaccine achieves durable viral clearance in vivo
Read More
GSK synthesizes novel interferon inducers
Read More
N30 Pharmaceuticals patents new alcohol dehydrogenase class-3 inhibitors
Read More
U.S. universities claim novel serotonin 5-HT2C receptor agonists
Read More
Boehringer Ingelheim begins new afatinib trials in breast cancer
Read More
Stellar Biotechnologies receives National Science Foundation grant
Read More
Talon Therapeutics and FDA reach agreement on HALLMARQ trial
Read More
Novartis seeks Japanese approval of tobramycin
Read More
Pharming returns certain Ruconest marketing rights to Swedish Orphan Biovitrum
Read More
Immuron to begin clinical testing of influenza product
Read More
Ipsen and Inspiration Biopharmaceuticals sign European partnership agreement in hemophilia
Read More
FDA grants fast track status to letermovir
Read More
Brain-penetrant inhibitor of kynurenine aminotransferase II described by Pfizer
Read More
Adimab announces new collaborations
Read More
FDA clears new anti-CCP assay for diagnosis of rheumatoid arthritis
Read More
NuPathe receives FDA complete response letter regarding Zelrix NDA
Read More
FDA accepts Relistor sNDA for filing
Read More
Cyclacel announces initiation of phase II trial of sapacitabine capsules
Read More